Abstract| Volume 39, ISSUE 9, SUPPLEMENT , e31-e32, September 2014

Outcome of Collagenase Injection Versus Fasciectomy in Treatment of Dupuytren Disease

Level 3 Evidence
      Comparing the efficacy of collagenase clostridium histolyticum injection versus fasciectomy in patients with Dupuytren’s contracture.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Becker G.
        • Davis T.
        The outcome of surgical treatments for primary Dupuytren’s disease- a systematic review.
        J Hand Surg Eur Vol. 2010; 35: 623-626
        • Badalamente M.A.
        • Hurst L.C.
        Enzyme injection as nonsurgical treatment of Dupuytren’s disease.
        J Hand Surg Am. 2000; 25: 629-636
        • Badalamente M.A.
        • Hurst L.C.
        • Hentz V.R.
        Collagen as a clinical target: nonoperative treatment of Dupuytren’s disease.
        J Hand Surg Am. 2002; 27: 788-798
        • Coert J.H.
        • Nerin J.P.
        • Meek M.F.
        Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients.
        Ann Plast Surg. 2006; 57: 13-17
        • Denkler K.
        Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.
        Eplasty. 2010; 10: e15
        • Gilpin D.
        • Coleman S.
        • Hall S.
        • Houston A.
        • Karrasch J.
        • Jones N.
        Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
        J Hand Surg Am. 2010; 35: 2027-2038
        • Hurst L.C.
        • Badalamente M.A.
        • Hentz V.R.
        • et al.
        Injectable collagenase clostridium histolyticum for Dupuytren’s contracture.
        N Engl J Med. 2009; 361: 968-979
        • Loos B.
        • Puschkin V.
        • Horch R.E.
        50 Years experience with Dupuytren’s contracture in the Erlangen University Hospital—a retrospective analysis of 2919 operated hands from 1956 to 2006.
        BMC Musculoskelet Disord. 2007; 8: 60
        • Naam N.H.
        Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren’s contracture.
        Hand (N Y). 2013; 8: 410-416
        • McMahon H.A.
        • Bachoura A.
        • Jacoby S.M.
        • Zelouf D.S.
        • Culp R.W.
        • Osterman A.L.
        Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren’s disease.
        Hand. 2013; 8: 261-266